Okay, let's tackle this question about the ideal treatment for metastatic choriocarcinoma in the lungs. First, I need to recall what choriocarcinoma is. It's a type of gestational trophoblastic disease, right? Highly malignant, but also very sensitive to chemotherapy.

The question is about metastatic disease, specifically in the lungs. So, the options probably include surgical resection, radiation, chemo, maybe some targeted therapy. The correct answer is likely a chemotherapy regimen. Common treatment protocols for gestational trophoblastic tumors include multi-agent chemotherapy, like the EMA/CO regimen. But wait, for choriocarcinoma, which is a high-risk GTD, the standard is usually a combination of etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine (EMA/CO).

Wait, but sometimes for high-risk cases, they might use a different regimen. Let me think. Choriocarcinoma is known for its high sensitivity to methotrexate and actinomycin D. However, metastatic disease usually requires more aggressive treatment. The EMA/CO regimen is often used for high-risk gestational trophoblastic neoplasia, which includes choriocarcinoma with metastases.

So, the correct answer would be the EMA/CO regimen. Let me check the options. If the options include chemotherapy, that's the way to go. Surgical resection might be considered in some cases, but for metastatic disease, chemo is the mainstay. Radiation is not typically used here because choriocarcinoma is chemo-sensitive. Targeted therapy or immunotherapy are not standard for this.

Therefore, the correct answer should be a combination chemotherapy regimen like EMA/CO. The options need to have this as one of the choices. The other options (surgery, radiation, single-agent chemo) are less effective or not standard. Let me structure the explanation accordingly.

**Core Concept**
Choriocarcinoma is a highly malignant, chemo-sensitive gestational trophoblastic tumor that spreads hematogenously, commonly to the lungs. Treatment relies on multi-agent chemotherapy due to its rapid response to systemic therapy.

**Why the Correct Answer is Right**
The **EMA/CO regimen** (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) is the first-line treatment for high-risk gestational trophoblastic neoplasia, including metastatic choriocarcinoma. This combination targets rapidly dividing trophoblastic cells, exploiting their high proliferative index. Platinum-based agents like etoposide enhance DNA damage, while methotrexate and actinomycin D inhibit folate metabolism and RNA synthesis, respectively.

**Why Each Wrong Option is Incorrect**
**Option A:** Surgical resection is reserved for localized disease or residual masses after chemotherapy.
**Option B:** Radiation therapy is ineffective due to choriocarcinoma’s chemo-sensitivity and poor radiosensitivity.
**Option C:** Single-agent methotrexate may suffice for low-risk cases but is insufficient for metastatic disease.

**Clinical Pearl / High-Yield Fact**
Choriocarcinoma

✓ Correct Answer: A. Chemotherapy